CARNEGIE MELLON UNIVERSITY
Clinical Trials
43
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (43 trials with phase data)• Click on a phase to view related trials
Drinking in Young Adult Duos (DYAD) Study
- Conditions
- Alcohol ConsumptionAlcohol DrinkingAlcohol Intoxication
- Interventions
- Other: Non-alcohol beverage
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-05-28
- Lead Sponsor
- Carnegie Mellon University
- Target Recruit Count
- 504
- Registration Number
- NCT06822257
- Locations
- 🇺🇸
Carnegie Mellon University, Pittsburgh, Pennsylvania, United States
Pilot Brief Communal Coping Intervention for Adults With Type 2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2024-06-14
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Carnegie Mellon University
- Target Recruit Count
- 62
- Registration Number
- NCT06459596
- Locations
- 🇺🇸
Carnegie Mellon University, Pittsburgh, Pennsylvania, United States
Evaluating FDA's Proposed Patient Medication Information Handout
- Conditions
- KnowledgeAttitude
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-06-18
- Lead Sponsor
- Carnegie Mellon University
- Target Recruit Count
- 330
- Registration Number
- NCT06320808
- Locations
- 🇺🇸
Carnegie Mellon University, Pittsburgh, Pennsylvania, United States
Game-based Pediatric Diabetes Education
- Conditions
- Diabetes Mellitus, Type 1Behavior, Health
- First Posted Date
- 2024-02-16
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Carnegie Mellon University
- Target Recruit Count
- 80
- Registration Number
- NCT06264258
- Locations
- 🇺🇸
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Pilot Brief Communal Coping Intervention for Adults With Type 1 Diabetes
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2023-06-29
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Carnegie Mellon University
- Target Recruit Count
- 80
- Registration Number
- NCT05925556
- Locations
- 🇺🇸
Carnegie Mellon University, Pittsburgh, Pennsylvania, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
FluidForm Bio Achieves Breakthrough in Vascularized Tissue Engineering for Diabetes Treatment
FluidForm Bio has developed an advanced FRESH 3D bioprinting technique using sacrificial gelatin microparticles that maintains cell viability five times deeper than traditional methods, addressing a critical limitation in tissue engineering.
Rice University's Bioelectronic Implant Targets Diabetes and Obesity with $34.9 Million Grant
Rice University received a $34.9 million grant to develop ROGUE, a bioelectronic implant for type 2 diabetes and obesity treatment, designed to improve patient adherence.